The use of a short-acting benzodiazepine to reduce the risk of syncopal episodes during upright stereotactic breast biopsy.
Clin Radiol
; 60(3): 394-6, 2005 Mar.
Article
em En
| MEDLINE
| ID: mdl-15710145
ABSTRACT
The use of sublingual lorazepam provides a safe and effective means of reducing the risk of syncopal episodes during upright stereotactic breast biopsy. Sublingual lorazepam, 2-4mg, was received by 19 women undergoing a total of 20 stereotactic procedures. Of 14 women who had previously fainted during upright stereotactic biopsy, 13 had a successful repeat biopsy following administration of sublingual lorazepam. All 4 women who received lorazepam for significant anxiety had successful biopsies. Stereotactic guided wire localization also was performed in 2 cases.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ansiedade
/
Síncope
/
Ansiolíticos
/
Doenças Mamárias
/
Lorazepam
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
Idioma:
En
Revista:
Clin Radiol
Ano de publicação:
2005
Tipo de documento:
Article
País de afiliação:
Reino Unido